Patents by Inventor Nanqun Zhu

Nanqun Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INFLAMMATORY DISEASE TREATMENT WITH COMPLEMENT INHIBITORS
    Publication number: 20220257697
    Abstract: The present disclosure provides methods of treating inflammatory indications with complement inhibitor compounds and compositions. Included are compounds and methods of treating neuromuscular inflammatory indications, such as Immune-Mediated Necrotizing Myopathy.
    Type: Application
    Filed: June 4, 2020
    Publication date: August 18, 2022
    Inventors: Petra DUDA, Ramin FARZANEH-FAR, Alonso RICARDO, Camil SAYEGH, Nanqun ZHU, Douangsone D. VADYSIRISACK, Olivier BOYER, Laurent DROUOT
  • MODULATORS OF COMPLEMENT ACTIVITY
    Publication number: 20220160820
    Abstract: The present disclosure provides compounds, compositions, and methods for modulating complement activity. Included are C5 inhibitor compounds and related methods of use in treating complement-related indications.
    Type: Application
    Filed: March 6, 2020
    Publication date: May 26, 2022
    Inventors: Zhong Ma, Nanqun Zhu, Evan Thackaberry, Ramin Farzaneh-Far, Alonso Ricardo
  • NEUROLOGICAL DISEASE TREATMENT WITH ZILUCOPLAN
    Publication number: 20220133841
    Abstract: Embodiments of the present disclosure include methods of treating myasthenia gravis, including generalized myasthenia gravis, by providing C5 complement inhibitors. Included are devices and kits for inhibitor administration and methods of evaluating complement inhibitor treatment efficacy.
    Type: Application
    Filed: October 22, 2019
    Publication date: May 5, 2022
    Inventors: Petra Duda, Ramin Farzaneh-Far, Zhong Ma, Nanqun Zhu, Evan Thackaberry, Alonso Ricardo